Advice
following a full submission:
levonorgestrel (Jaydess®) is accepted for use within NHS Scotland.
Indication under review: Contraception for up to 3 years.
A phase III, open-label, randomised study confirmed the contraceptive efficacy of levonorgestrel 13.5mg intrauterine delivery system according to the Pearl Index.
Download detailed advice186KB (PDF)
Medicine details
- Medicine name:
- levonorgestrel (Jaydess)
- SMC ID:
- 1036/15
- Indication:
- Contraception for up to 3 years.
- Pharmaceutical company
- Bayer plc/Bayer Schering Pharma
- BNF chapter
- Obstetrics, gynaecology, and urinary-tract disorders
- Submission type
- Full
- Status
- Accepted
- Date advice published
- 13 April 2015